Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between ...

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, to reduce the risk of kidney failure and ...

Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...

Health Canada has approved Ozempic for use by Type 2 diabetes patients to reduce the risk of further kidney damage.

The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1 mg demonstrated ...

Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting ...

Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...

According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...